Sign in

CIK 0001124105

  • Accelerated filer
  • Smaller reporting company

GYRE THERAPEUTICS, INC.

Sign in to watch
Ticker
GYRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
562020050
Phone
+1 858-284-0115
Business address
12730 HIGH BLUFF DRIVE, SUITE 250, SAN DIEGO, CA, 92130
Former names
CATALYST BIOSCIENCES, INC., TARGACEPT INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-01-16 SELICK HAROLD E Director Returned to the company · Stock Option (Right to Buy) −450 0
2018-01-16 SELICK HAROLD E Director Grant or award · Stock Option (Right to Buy) +450 450
2018-01-16 SELICK HAROLD E Director Returned to the company · Stock Option (Right to Buy) −500 0
2018-01-16 SELICK HAROLD E Director Grant or award · Stock Option (Right to Buy) +500 500
2018-01-16 SELICK HAROLD E Director Returned to the company · Stock Option (Right to Buy) −10,000 0
2018-01-16 SELICK HAROLD E Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2018-01-12 USMAN NASSIM President and CEO Grant or award · Stock Option(Right to Buy) +95,000 95,000
2018-01-12 Payne Fletcher Chief Financial Officer Grant or award · Stock Option (Right to Buy) +26,000 26,000
2018-01-12 Levy Howard Chief Medical Officer Grant or award · Stock Option(Right to Buy) +33,000 33,000
2018-01-02 Williams Eddie Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2017-12-20 Richard John P Director Other disposition · Redeemable Convertible Note −0
2017-10-25 Hunt Andrea Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2017-07-13 Richard John P Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2017-07-13 SELICK HAROLD E Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2017-07-13 LAWLOR AUGUSTINE Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2017-07-13 HILL STEPHEN A Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2017-07-13 DESOUZA ERROL B Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2017-07-11 Levy Howard Chief Medical Officer Grant or award · Stock Option (Right to Buy) +95,000 95,000
2017-07-11 Payne Fletcher Chief Financial Officer Grant or award · Stock Option (Right to Buy) +75,000 75,000
2017-07-11 USMAN NASSIM President & CEO Grant or award · Stock Option (Right to Buy) +275,000 275,000

Page 22 of 24 · 471 trades